United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87063-192_5136a714-d33e-d2c8-e063-6294a90a0982
- Product NDC
- 87063-192
- Form
- TABLET
- Composition / generic term
- Levetiracetam
- Labeler
- ASCLEMED USA INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230501
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVETIRACETAM — 750 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (87063-192-12) · 87063-192-12
- 30 TABLET in 1 BOTTLE (87063-192-30) · 87063-192-30
- 60 TABLET in 1 BOTTLE (87063-192-60) · 87063-192-60
- 90 TABLET in 1 BOTTLE (87063-192-90) · 87063-192-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →